Evidence map›Paper›PMID 34837094›Full record

ReviewPathologica2021

Juan Rosai as master of our comprehensive understanding of thymus and thymoma.

Mirella Marino, Alexander Marx, Lucia Anemona, Libero Lauriola, Philipp Ströbel, Hans Konrad Müller-Hermelink

Abstract readReview
In one paragraph

Review in Pathologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mirella MarinoDepartment of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Alexander MarxInstitute of Pathology, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.
Lucia AnemonaDepartment of Experimental Medicine, Faculty of Medicine, Tor Vergata University, Rome, Italy.
Libero LauriolaDepartment of Anatomic Pathology, Catholic University, Rome, Italy.
Philipp StröbelUniversity Medical Center Göttingen, Göttingen, Germany.
Hans Konrad Müller-HermelinkInstitute of Pathology, University of Würzburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the authors report on the activity of Juan Rosai, one of the pathologists most engaged in the definition of cells, diseases and tumors occurring in the thymus and in the mediastinum during the last 60 years. With his morphological skills and tireless interest in clarification of disease patterns, he contributed extraordinarily to expand our knowledge of the mediastinal diseases and to improve our diagnostic approach. He determined extraordinary advances also in trasmission electron microscopy and in immunohistochemistry as powerful diagnostic tools. Moreover, he proposed and promoted, together with an international panel of Pathologists, the World Health Classification of Thymic tumors as a definite progress in our comprehension and diagnostics of thymic epithelial tumors (TET). Our purpose is to review J. Rosai's achievements in thymic normal structure, in TET and particularly in the entity now definied as "thymoma", in distinction from the thymic carcinoma. To do this, our narrative will also be based on personal memories, longstanding collaborations and/or friendship with J. Rosai.

Indexed as

Neoplasms, Glandular and EpithelialThymomaThymus NeoplasmsHumansImmunohistochemistryMaleMediastinumclassificationmediastinumpathologythymomathymus

Identifiers

PMID34837094
PMCPMC8720410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.